INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 186 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,396 | +67.6% | 345 | 0.0% | 0.00% | – |
Q2 2023 | $3,816 | +76220.0% | 345 | -6.0% | 0.00% | – |
Q1 2023 | $5 | 0.0% | 367 | 0.0% | 0.00% | – |
Q4 2022 | $5 | -99.9% | 367 | +6.4% | 0.00% | – |
Q3 2022 | $5,000 | 0.0% | 345 | 0.0% | 0.00% | – |
Q2 2022 | $5,000 | -16.7% | 345 | 0.0% | 0.00% | – |
Q1 2022 | $6,000 | 0.0% | 345 | 0.0% | 0.00% | – |
Q4 2021 | $6,000 | -90.0% | 345 | -91.5% | 0.00% | – |
Q3 2021 | $60,000 | -25.9% | 4,045 | 0.0% | 0.00% | -100.0% |
Q2 2021 | $81,000 | +912.5% | 4,045 | +1072.5% | 0.00% | – |
Q1 2021 | $8,000 | -11.1% | 345 | 0.0% | 0.00% | – |
Q4 2020 | $9,000 | -82.0% | 345 | -71.1% | 0.00% | – |
Q3 2020 | $50,000 | +455.6% | 1,195 | +512.8% | 0.00% | – |
Q2 2020 | $9,000 | -18.2% | 195 | +8.3% | 0.00% | – |
Q1 2020 | $11,000 | -70.3% | 180 | -40.0% | 0.00% | – |
Q4 2019 | $37,000 | +428.6% | 300 | +200.0% | 0.00% | – |
Q3 2019 | $7,000 | -12.5% | 100 | 0.0% | 0.00% | – |
Q2 2019 | $8,000 | -27.3% | 100 | 0.0% | 0.00% | – |
Q1 2019 | $11,000 | +10.0% | 100 | 0.0% | 0.00% | – |
Q4 2018 | $10,000 | -23.1% | 100 | 0.0% | 0.00% | – |
Q3 2018 | $13,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |